Skip to Content
Merck

Bivalent molecular probes for dopamine D2-like receptors.

Bioorganic & medicinal chemistry (2011-11-22)
Daniela Huber, Stefan Löber, Harald Hübner, Peter Gmeiner
ABSTRACT

Merging two arylamidoalkyl substituted phenylpiperazines as prototypical recognition elements for dopamine D(2)-like receptors by oligoethylene glycol linkers led to a series of bivalent ligands. These dimers were investigated in comparison to their monomeric analogues for their dopamine D(2long), D(2short), D(3) and D(4) receptor binding. Radioligand binding experiments revealed strong bivalent effects for some para-substituted benzamide derivatives. For the D(3) subtype, the target compounds 32, 34 and 36 showed an up to 70-fold increase of affinity and a substantial enhancement of subtype selectivity when compared to the monovalent analogue 24. Analysis of the binding curves displayed Hill slopes very close to one indicating that the bivalent ligands displace 1equiv of radioligand. Obviously, the two pharmacophores occupy an orthosteric and an allosteric binding site rather than adopting a receptor-bridging binding mode.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Phenylpiperazine, ≥97.0%